Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review
Authors:
- Sarah J NolanSarah J Nolan
- Maria SudellMSMaria Sudell
- Catrin Tudur SmithCSCatrin Tudur Smith
- Anthony G MarsonAMAnthony G Marson
- 28 January 2016
- reference entry
- Published by Wiley
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2015
- Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the childCochrane Database of Systematic Reviews, 2014
- An unknown quantity—The worldwide prevalence of epilepsyEpilepsia, 2014
- Topiramate in pregnancyNeurology, 2008
- How common are the “common” neurologic disorders?Neurology, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Considerations on Designing Clinical Trials to Evaluate the Place of New Antiepileptic Drugs in the Treatment of Newly Diagnosed and Chronic Patients with EpilepsyEpilepsia, 1998
- Antiepileptic DrugsNew England Journal of Medicine, 1996
- Remission of epilepsy: results from the National General Practice Study of EpilepsyThe Lancet, 1995
- Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984Epilepsia, 1993